Science and Research

ASCENT - Asthma Control in Severe Asthma Patients Treated with Tezepelumab: a Prospective, Observational, Real-World Evidence Study

To describe participant-reported asthma symptom control using the Asthma Control Questionnaire (ACQ-6) at baselinea and up to 52 weeks following tezepelumab initiation

Study details
DZL Disease Area: AA
DZL Disease Area: AA
Study Type: Observational
Study Type: Observational
DZL Role: DZL recruiting center
DZL Role: DZL recruiting center
Funding: Externally - industry
Funding: Externally - industry
DZL Participating Sites: BREATH
DZL Participating Sites: BREATH
Start Date: 06.10.2023
Completion Date: 03.02.2025
Status: Active / not recruiting
Status: Active / not recruiting
DZL recruiting center


close
chevron-down

Unsere Seite verwendet Cookies und ähnliche Technologien. Mit der Nutzung der Webseite stimmen Sie der Verwendung von Cookies zu. Mehr Informationen dazu finden Sie in unserer Datenschutzerklärung.